These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 9554256)
1. Adjuvants and delivery systems for viral vaccines--mechanisms and potential. Jennings R; Simms JR; Heath AW Dev Biol Stand; 1998; 92():19-28. PubMed ID: 9554256 [TBL] [Abstract][Full Text] [Related]
2. Immunity in response to particulate antigen-delivery systems. Storni T; Kündig TM; Senti G; Johansen P Adv Drug Deliv Rev; 2005 Jan; 57(3):333-55. PubMed ID: 15560945 [TBL] [Abstract][Full Text] [Related]
3. Adjuvants and delivery issues related to immunization: a survey of the recent patent literature. Mrsny RJ J Drug Target; 1998; 6(4):243-9. PubMed ID: 9894692 [TBL] [Abstract][Full Text] [Related]
4. Adjuvants in perspective. Vogel FR Dev Biol Stand; 1998; 92():241-8. PubMed ID: 9554280 [TBL] [Abstract][Full Text] [Related]
5. Recent developments in adjuvants for vaccines against infectious diseases. O'Hagan DT; MacKichan ML; Singh M Biomol Eng; 2001 Oct; 18(3):69-85. PubMed ID: 11566599 [TBL] [Abstract][Full Text] [Related]
6. Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens. Dey AK; Srivastava IK Expert Rev Vaccines; 2011 Feb; 10(2):227-51. PubMed ID: 21105782 [TBL] [Abstract][Full Text] [Related]
7. ISCOMs and ISCOMATRIX. Sun HX; Xie Y; Ye YP Vaccine; 2009 Jul; 27(33):4388-401. PubMed ID: 19450632 [TBL] [Abstract][Full Text] [Related]
8. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens. Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624 [TBL] [Abstract][Full Text] [Related]
9. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems. Gupta RK; Chang AC; Siber GR Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260 [TBL] [Abstract][Full Text] [Related]
10. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers. Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264 [TBL] [Abstract][Full Text] [Related]
11. Poly(gamma-glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an AIDS vaccine. Wang X; Uto T; Akagi T; Akashi M; Baba M J Med Virol; 2008 Jan; 80(1):11-9. PubMed ID: 18041033 [TBL] [Abstract][Full Text] [Related]
12. CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases. Klinman DM; Klaschik S; Sato T; Tross D Adv Drug Deliv Rev; 2009 Mar; 61(3):248-55. PubMed ID: 19272313 [TBL] [Abstract][Full Text] [Related]
13. The relevance of cytokines for development of protective immunity and rational design of vaccines. Chabalgoity JA; Baz A; Rial A; Grille S Cytokine Growth Factor Rev; 2007; 18(1-2):195-207. PubMed ID: 17347024 [TBL] [Abstract][Full Text] [Related]
14. Unmet needs in modern vaccinology: adjuvants to improve the immune response. Leroux-Roels G Vaccine; 2010 Aug; 28 Suppl 3():C25-36. PubMed ID: 20713254 [TBL] [Abstract][Full Text] [Related]
15. Induction and direction of immune responses by vaccine adjuvants. Schijns VE Crit Rev Immunol; 2001; 21(1-3):75-85. PubMed ID: 11642615 [TBL] [Abstract][Full Text] [Related]
16. European union regulatory developments for new vaccine adjuvants and delivery systems. Sesardic D; Dobbelaer R Vaccine; 2004 Jun; 22(19):2452-6. PubMed ID: 15193409 [TBL] [Abstract][Full Text] [Related]
18. New generation of mucosal adjuvants for the induction of protective immunity. Yuki Y; Kiyono H Rev Med Virol; 2003; 13(5):293-310. PubMed ID: 12931340 [TBL] [Abstract][Full Text] [Related]
19. Humoral response to HSV-1 subunit vaccines--a statistical analysis. Simms JR; Heath AW; Richardson VJ; Jennings R Dev Biol Stand; 1998; 92():335-40. PubMed ID: 9554289 [TBL] [Abstract][Full Text] [Related]
20. [Adjuvants--essential components of new generation vaccines]. Dzierzbicka K; Kołodziejczyk AM Postepy Biochem; 2006; 52(2):204-11. PubMed ID: 17078510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]